BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32274713)

  • 1. Heparanase-The Message Comes in Different Flavors.
    Ilan N; Bhattacharya U; Barash U; Boyango I; Yanku Y; Gross-Cohen M; Vlodavsky I
    Adv Exp Med Biol; 2020; 1221():253-283. PubMed ID: 32274713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
    Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
    Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparanase: Historical Aspects and Future Perspectives.
    Khanna M; Parish CR
    Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of heparanase inhibitors in cancer therapy.
    Heyman B; Yang Y
    Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparanase promotes glioma progression via enhancing CD24 expression.
    Barash U; Spyrou A; Liu P; Vlodavsky E; Zhu C; Luo J; Su D; Ilan N; Forsberg-Nilsson K; Vlodavsky I; Yang X
    Int J Cancer; 2019 Sep; 145(6):1596-1608. PubMed ID: 31032901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action.
    Weissmann M; Bhattacharya U; Feld S; Hammond E; Ilan N; Vlodavsky I
    Matrix Biol; 2019 Apr; 77():58-72. PubMed ID: 30096360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase.
    Dai X; Yan J; Fu X; Pan Q; Sun D; Xu Y; Wang J; Nie L; Tong L; Shen A; Zheng M; Huang M; Tan M; Liu H; Huang X; Ding J; Geng M
    Clin Cancer Res; 2017 Oct; 23(20):6267-6278. PubMed ID: 28710312
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth.
    Gross-Cohen M; Feld S; Doweck I; Neufeld G; Hasson P; Arvatz G; Barash U; Naroditsky I; Ilan N; Vlodavsky I
    Cancer Res; 2016 May; 76(9):2791-801. PubMed ID: 27013193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
    Ilan N; Elkin M; Vlodavsky I
    Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity and structure-activity relationship of heparanase inhibitors: Recent advances.
    Fu K; Bai Z; Chen L; Ye W; Wang M; Hu J; Liu C; Zhou W
    Eur J Med Chem; 2020 May; 193():112221. PubMed ID: 32222663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Good and Bad Sides of Heparanase-1 and Heparanase-2.
    Pinhal MAS; Melo CM; Nader HB
    Adv Exp Med Biol; 2020; 1221():821-845. PubMed ID: 32274740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3.
    Knani I; Singh P; Gross-Cohen M; Aviram S; Ilan N; Sanderson RD; Aronheim A; Vlodavsky I
    Matrix Biol; 2022 Jan; 105():17-30. PubMed ID: 34808335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression.
    Singh P; Blatt A; Feld S; Zohar Y; Saadi E; Barki-Harrington L; Hammond E; Ilan N; Vlodavsky I; Chowers Y; Half E
    Neoplasia; 2017 Mar; 19(3):175-184. PubMed ID: 28147305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the discovery of heparanase inhibitors as anti-cancer agents.
    Jia L; Ma S
    Eur J Med Chem; 2016 Oct; 121():209-220. PubMed ID: 27240275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pro-Tumorigenic Effect of Heparanase 2 (Hpa2) in Thyroid Carcinoma Involves Its Localization to the Nuclear Membrane.
    Margulis I; Naroditsky I; Gross-Cohen M; Ilan N; Vlodavsky I; Doweck I
    Front Oncol; 2021; 11():645524. PubMed ID: 33959505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of heparanase inhibitors for anti-cancer therapy.
    Miao HQ; Liu H; Navarro E; Kussie P; Zhu Z
    Curr Med Chem; 2006; 13(18):2101-11. PubMed ID: 16918340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
    Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
    J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of heparanase 2 (Hpa2) in gastric cancer.
    Liu J; Knani I; Gross-Cohen M; Hu J; Wang S; Tang L; Ilan N; Yang S; Vlodavsky I
    Neoplasia; 2021 Sep; 23(9):966-978. PubMed ID: 34343822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior.
    Bandari SK; Purushothaman A; Ramani VC; Brinkley GJ; Chandrashekar DS; Varambally S; Mobley JA; Zhang Y; Brown EE; Vlodavsky I; Sanderson RD
    Matrix Biol; 2018 Jan; 65():104-118. PubMed ID: 28888912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparanase Inhibition by Pixatimod (PG545): Basic Aspects and Future Perspectives.
    Hammond E; Dredge K
    Adv Exp Med Biol; 2020; 1221():539-565. PubMed ID: 32274726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.